Blog

Philly Trading Card Startup CollX Raises $10M Series A, Will Focus On Growing Community

February 20, 2025

While the company is largely a marketplace for buying and selling collectibles, it wants to help users connect with one another. Philly-based trading card platform CollX raked in millions more dollars last month, once again receiving support from local investors. CollX raised a $10 million Series A, with plans to use the funding for marketing and […]

Read More

Experian Accelerates Identity and Activation Capabilities With Acquisition of Audigent

December 4, 2024

December 04 – COSTA MESA, Calif.–(BUSINESS WIRE)–Experian® — the global data and technology company — announced today it has acquired Audigent, a leading data activation and identity platform in the advertising industry. The acquisition further expands Experian’s deeply integrated marketing data and identity capabilities in the advertising ecosystem. With the addition of Audigent’s combined first-party publisher […]

Read More

PolicyMap Integrates Maternal Health Index to Combat Disparities

December 1, 2024

PHILADELPHIA, PA – PolicyMap, an online data and mapping company, has announced the integration of Surgo Health’s Granular Maternity Vulnerability Index (gMVI) into its platform. This powerful tool aims to address maternal health disparities in the United States by identifying areas where mothers face the greatest risks to their health and well-being. The U.S. has one […]

Read More

BioBuzz Announces The Finalists For Its 2024 Life Sciences Awards In The BioHealth Capital Region And Greater Philadelphia

November 20, 2024

BioBuzz recognizes six categories annually: BioHealth Leader of the Year, Community Builder of the Year, Workforce Champion of the Year, Startup of the Year, Breakthrough Life Science Company of the Year, and Employer of the Year. Meet the people, programs, and organizations who made noteworthy impact regionally in the life sciences in 2024. BALTIMORE, Nov. 20, […]

Read More

Vittoria Biotherapeutics Completes $25 Million In Private Financing To Propel Groundbreaking Cell Therapy Candidates

November 12, 2024

PHILADELPHIA, Nov. 12, 2024 (GLOBE NEWSWIRE) — Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company specializing in the development of innovative cell therapies for hard-to-treat diseases, today announced the successful completion of a $25 million private financing round. This funding is a $10 million extension to its previous $15 million financing secured in November 2023. The latest […]

Read More

Previous Next